Henry Rappaport

13.1k citations

179 papers · 10.0k indexed · 3 hit papers · h-index 51

Impact in

Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment
Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research

Papers in

Genetics 63
- Chronic Lymphocytic Leukemia Research 55
Pathology and Forensic Medicine 92
- Lymphoma Diagnosis and Treatment 88

Co-authors: Bharat N. Nathwani Edgar M. Moran Carl D. Winberg Hun Kim Glauco Frizzera Khalil Sheibani Gerassimos A. Pangalis Jerome S. Burke
Journals: Cancer (53 papers)American Journal of Clinical Pathology (15 papers)Blood (13 papers)Human Pathology (10 papers)JNCI Journal of the National Cancer Institute (5 papers)
Partner nations: United States France United Kingdom

In The Last Decade

Henry Rappaport

177 papers receiving 8.5k citations

Hit Papers

align trajectories log scale

ANGIO-IMMUNOBLASTIC LYMPHADENOPATHY WITH DYSPROTEINÆMIA 1974 · 387 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1974 The Lancet
1966 Tumors of the hematopoietic system
1956 Cancer

Peers

Countries citing papers authored by Henry Rappaport

Since Specialization

Citations

This map shows the geographic impact of Henry Rappaport's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Rappaport with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Rappaport more than expected).

Fields of papers citing papers by Henry Rappaport

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Rappaport. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Rappaport. The network helps show where Henry Rappaport may publish in the future.

Co-authors

The 25 scholars most cited alongside Henry Rappaport, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Henry Rappaport Line = papers co-authored together Henry Rappaport links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Novel Method for the Detection, Quantitation, and Breakpoint Cluster Region Determination of t(15;17) Fusion Transcripts Using a One-Step Real-Time Multiplex RT-PCR American Journal of Clinical Pathology ·Paul Choppa, Marilyn A. Owens, Jamie Gomez, Henry Rappaport, Jean Lopategui, Horacio G. Vall	2003	13
2	Rosette‐forming non‐Hodgkin's lymphomas Histopathology ·Chae H. Koo, Stephanie Shin, F. BRACHO, W. H. Johnston, Henry Rappaport	1996	8
3	Monocytoid B-cell lymphoma in patients with Sjögren's syndrome: A clinicopathologic study of 13 patients Human Pathology ·Sung Sik Shin, Khalil Sheibani, Andrew J. Fishleder, Jonathan Ben‐Ezra, Anne Bailey, Chae H. Koo, Jerome S. Burke, Raymond Tubbs, Henry Rappaport	1991	61
4	Genotype and phenotype: A practical approach to the immunogenetic analysis of lymphoproliferative disorders Human Pathology ·Anna M. Wu, Carl D. Winberg, Khalil Sheibani, Anne Colombero, R. Bruce Wallace, Henry Rappaport	1990	5
5	Cytogenetic studies of Hodgkin's disease Cancer Genetics and Cytogenetics ·Thomas R. Dennis, A.D. Stock, Carl D. Winberg, Khalil Sheibani, Henry Rappaport	1989	15
6	Relationship between eosinophil density and T-cell activation markers in lymph nodes of patients with Hodgkin's disease Human Pathology ·Jonathan Ben‐Ezra, Khalil Sheibani, William G. Swartz, Robert Stroup, S. Thomas Traweek, Janice Kezirian, Henry Rappaport	1989	9
7	Antigenic phenotype of Langerhans cell histiocytosis: An immunohistochemical study demonstrating the value of LN-2, LN-3, and Vimentin Human Pathology ·Norio Azumi, Khalil Sheibani, William G. Swartz, Robert Stroup, Henry Rappaport	1988	25
8	Differential expression of adenosine deaminase isozymes in acute leukemia Blood ·Howard Ratech, Frank Martiniuk, WZ Borer, Henry Rappaport	1988	32
9	Castleman's disease of the leptomeninges Journal of neurosurgery ·Gregory S. Severson, Douglas S. Harrington, Dennis D. Weisenburger, Rodney D. McComb, John H. Casey, Benjamin R. Gelber, B Varet, R Abélanet, Henry Rappaport	1988	36
10	Leu-9 (CD 7) positivity in acute leukemias: a marker of T-cell lineage? PubMed ·Jonathan Ben‐Ezra, Carl D. Winberg, Anna M. Wu, Henry Rappaport	1987	7
11	Distinction between Undifferentiated (Small Noncleaved) and Lymphoblastic Lymphoma The American Journal of Surgical Pathology ·Mark Brownell, Khalil Sheibani, Hector Battifora, Carl D. Winberg, Henry Rappaport	1987	9
12	Legionnaires' disease The American Journal of Medicine ·Dennis D. Weisenburger, Henry Rappaport, Muneshwar S. Ahluwalia, Ramesh Melvani, Edward D. Renner	1980	18
13	Histopathologic sequence of events in adult mice undergoing lethal graft-versus-host reaction developed across H-2 and/or non-H-2 histocompatibility barriers. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Henry Rappaport, A Khalil, O Hallé-Pannenko, Linda L. Pritchard, D Dantchev, G Mathé	1979	75
14	Comparative study of the histologic reactions to intravenous injections of heat-killed Pseudomonas aeruginosa and of BCG. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·A Khalil, Henry Rappaport, I. Florentin, Myriam Bennoun, M. Davigny, G Mathé	1979	3
15	Acute (“malignant”) myelosclerosis Cancer ·Robert M. Bearman, Gerassimos A. Pangalis, Henry Rappaport	1979	92
16	Long-term survival of patients with acute differentiated histocytosis (letterersiwe disease) Cancer ·Katherine G. Doede, Henry Rappaport	1967	29
17	Discussion on: The Pathology and Nomenclature of Hodgkin's Disease Cancer Research ·Henry Rappaport	1966	3
18	Tumors of the hematopoietic system Henry Rappaport Hit paper breakdown →	1966	727
19	A Study of the Pathogenesis of Malignant Lymphoma Induced in the Swiss Mouse by 7,12-Dimethylbenz[a]anthracene Injected at Birth Cancer Research ·Henry Rappaport, Carlo Baroni	1962	37
20	The Induction of Melanotic Tumors Resembling Cellular Blue Nevi in the Syrian White Hamster by Cutaneous Application of 7,12-Dimethylbenz[a]anthracene Cancer Research ·Henry Rappaport, Giuseppe Pietra, Philippe Shubik	1961	23

About Henry Rappaport

Henry Rappaport is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Dermatology and Immunology, having authored 179 papers that have together received 10.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (88 papers), Chronic Lymphocytic Leukemia Research (55 papers), Viral-associated cancers and disorders (19 papers), Acute Lymphoblastic Leukemia research (15 papers), Cutaneous lymphoproliferative disorders research (14 papers), Lung Cancer Treatments and Mutations (12 papers), Histiocytic Disorders and Treatments (11 papers) and Acute Myeloid Leukemia Research (10 papers). The work is most often cited by research in Pathology and Forensic Medicine (5.8k citations), Genetics (2.9k citations), Dermatology (1.5k citations), Oncology (3.7k citations) and Immunology (1.9k citations). Henry Rappaport has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Bharat N. Nathwani, Edgar M. Moran, Carl D. Winberg, Hun Kim, Glauco Frizzera, Khalil Sheibani, Gerassimos A. Pangalis, Jerome S. Burke, Dennis D. Weisenburger and Louis B. Thomas. Their work appears in journals such as Cancer, American Journal of Clinical Pathology, Blood, Human Pathology and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact